The KLOW four-peptide regenerative blend in oral capsule form with added KPV anti-inflammatory support.
The KLOW Blend capsule builds upon the GLOW formula (GHK-Cu, BPC-157, TB-500) by adding KPV, a tripeptide derived from the C-terminal sequence of alpha-melanocyte stimulating hormone (alpha-MSH). KPV (Lys-Pro-Val) is one of the most potent anti-inflammatory tripeptides known, capable of directly penetrating intestinal epithelial cells to inhibit NF-kB signaling from within. This makes the KLOW Blend particularly valuable for inflammatory bowel conditions, leaky gut syndrome, and any condition where intestinal inflammation is a primary concern. The addition of KPV to the regenerative trio of GHK-Cu, BPC-157, and TB-500 creates a comprehensive formula that addresses both the inflammatory and structural dimensions of intestinal healing. Research in animal models of colitis has shown that oral KPV significantly reduces intestinal inflammation, shortens healing time, and improves barrier function markers.
Oral capsule
“The KLOW four-peptide regenerative blend in oral capsule form with added KPV anti-inflammatory support.”
GHK-Cu modulates gene expression through AP-1 and SP1 transcription factor activation, promoting collagen synthesis, antioxidant defense, and anti-inflammatory signaling. BPC-157 promotes GI mucosal repair through FAK-paxillin pathway activation and VEGF-mediated angiogenesis, while inhibiting NF-kB to reduce inflammation. TB-500 regulates actin dynamics through G-actin sequestration, facilitating cell migration and wound closure in the intestinal mucosa. KPV activates melanocortin receptor 1 (MC1R) on intestinal epithelial cells and macrophages, triggering intracellular signaling that prevents NF-kB nuclear translocation and reduces transcription of pro-inflammatory cytokines including IL-1beta, IL-6, and TNF-alpha. The unique advantage of KPV is its ability to directly penetrate intestinal epithelial cells, allowing it to act from within the cell rather than only from the luminal surface. Together, these four compounds provide comprehensive intestinal healing through complementary anti-inflammatory, angiogenic, and structural repair mechanisms.
One capsule (per prescriber guidance)
Take on empty stomach. Particularly valuable for IBD, leaky gut, and inflammatory conditions alongside tissue repair goals.
When sourcing KLOW Blend (Capsule) for research purposes, the following quality benchmarks should be verified before use.
>98% (verified by HPLC)
Must be provided by supplier
<0.1 EU/mg (prevents bacterial contamination)
Manufactured in cGMP-certified facility
Independent lab verification preferred
Store at room temperature, away from light and moisture.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Primarily animal studies with limited human data. Mechanism is plausible but clinical efficacy is unconfirmed.
Peptides commonly used alongside KLOW Blend (Capsule) for synergistic effects.
The most clinically validated immunomodulatory peptide, approved in 35+ countries for hepatitis, sepsis, and immune deficiency.
The GLOW regenerative triple blend in convenient oral capsule form for skin, healing, and anti-aging support.
Category
Status
Dose
Frequency
Cycle
Peptides
Protocols
Other Pages
Contact Us Today!
© 2026 Best Health IQ. All rights reserved.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many compounds described on this site are not approved by the FDA for human therapeutic use. Some are available only as compounded preparations or as materials sold for laboratory use, and several are on FDA's Category 2 list for significant safety risks. Nothing on this site constitutes medical advice or a recommendation to use any compound described.